Table 4.
Variable | n | OR (95% CI) | P-value |
---|---|---|---|
Age | |||
<30 | 28 | 1 | |
31–40 | 41 | 2.674 (0.621–11.506) | 0.187 |
41–50 | 23 | 6.721 (1.334–33.858) | 0.021* |
51–60 | 12 | 1.852 (0.280–12.240) | 0.523 |
60+ | 5 | 1.156 (0.057–23.424) | 0.925 |
Gender | |||
Male | 67 | 1 | |
Female | 42 | 1.568 (0.467–5.261) | 0.466 |
BMI (kg/m2) | |||
<25 | 44 | 1 | |
25–30 | 37 | 0.435 (0.109–1.731) | 0.237 |
30–35 | 12 | 1.662 (0.280–9.868) | 0.576 |
>35 | 16 | 3.911 (0.845–18.108) | 0.081 |
Prior cannabis usage status | |||
Current user | 53 | 1 | |
Ex-user | 29 | 1.031 (0.299–3.551) | 0.961 |
Never used | 27 | 0.958 (0.196–4.685) | 0.958 |
CBMP prescription | |||
Oils | 34 | 1 | |
Dried flower | 48 | 21.964 (0.752–641.491) | 0.073 |
Both | 27 | 11.563 (0.442–302.527) | 0.142 |
CBD contents in CBMP | |||
No CBD | 13 | 1 | |
≤ Median dose of cohort (≤31.25 mg/day) | 41 | 4.583 (0.625–33.605) | 0.134 |
> Median dose of cohort (>31.25 mg/day) | 55 | 3.248 (0.417–25.316) | 0.261 |
THC contents in CBMP | |||
≤ Median dose of cohort (≤100.00 mg/day) | 40 | 1 | |
> Median dose of cohort (>100.00 mg/day) | 69 | 0.311 (0.021–4.680) | 0.398 |
Baseline GAD-7 score | |||
0–9 (minimal or mild) | 23 | 1 | |
10–14 (moderate) | 30 | 4.537 (0.735–28.004) | 0.103 |
15–21 (severe) | 56 | 16.018 (2.157–118.963) | 0.007** |
Baseline SQS score | |||
≤ 3 (sleep impaired) | 61 | 1 | |
> 3 (non-sleep impaired) | 48 | 0.991 (0.320–3.066) | 0.987 |
Significant differences are denoted by asterisks (*P < 0.050,**P = 0.010, and ***P < 0.001).